Associated Papers
Targeting SOS1 overcomes imatinib resistance with BCR-ABL independence through uptake transporter SLC22A4 in CML.
Liu Y et al.
Molecular Therapy Oncolytics, 2021
34938856 (PubMed )
Supplement: mmc2.pdf
Pharmacogenetics of hepatocellular carcinoma and cholangiocarcinoma.
Alonso-Peña M et al.
Cancer Drug Resistance (alhambra, Calif.), 2019
Select a paper to view details